Print

New ANDA Cases

Case Name

Date Filed

Judge

Drug

Patent No(s).

Teva Pharma. USA Inc. v. Synthon Pharma., Inc., 12-2556 (S.D.N.Y.)

Apr. 3, 2012

Hon. Barbara S. Jones

Copaxone® (glatiramer acetate injection)

7,199,098

6,939,539

6,054,430

6,620,847

5,981,589

6,342,476

6,362,161

AR Holding Co., Inc. v. Par Pharma., Inc., 12-0419 (D. Del.)

Apr. 4, 2012

Hon. Mary Pat Thynge

Colcrys® (colchicine USP)

7,619,004

7,601,758

7,820,681

7,915,269

7,964,647

7,964,648

7,981,938

8,093,296

8,093,297

8,097,655

Teva Pharma. USA, Inc. v. Synthon Pharma., Inc., 12-0179 (E.D.N.C.)

Apr. 4, 2012

Hon. James C. Dever, III

Copaxone® (glatiramer acetate injection)

7,199,098

6,939,539

6,054,430

6,620,847

5,981,589

6,342,476

6,362,161

Allergan Sales, LLC v. Akorn, Inc., 12-0175 (E.D. Tex.)

Apr. 4, 2012

Hon. Rodney Gilstrap

Acular LS® (ketorolac tromethamine ophthalmic solution, 0.4%)

8,008,338

Allergan Sales, LLC v. Alcon Research, Ltd., 12-0177 (E.D. Tex.)

Apr. 4, 2012

Hon. Rodney Gilstrap

Acular LS® (ketorolac tromethamine ophthalmic solution, 0.4%)

8,008,338

Allergan Sales, LLC v. Apotex, Inc., 12-0178 (E.D. Tex.)

Apr. 4, 2012

Hon. Rodney Gilstrap

Acular LS® (ketorolac tromethamine ophthalmic solution, 0.4%)

8,008,338

Sanofi-Aventis U.S. LLC v. Strides, Inc., 12-2070 (D.N.J.)

Apr. 5, 2012

Hon. Joel A. Pisano

Eloxatin® (oxaliplatin injection)

5,338,874

5,716,988

Abbott Labs. v. Roxane Labs., Inc., 12-0457 (D. Del.)

Apr. 10, 2012

Hon. Christopher J. Burke

Norvir® (ritonavir tablets)

7,148,359

7,364,752

5,648,497

Depomed, Inc. v. Impax Labs., Inc., 12-2154 (D.N.J.)

Apr. 10, 2012

Hon. Joel A. Pisano

Gralise® (gabapentin tablets)

6,340,475

6,488,962

6,635,280

6,723,340

7,438,927

7,731,989

Roxane Labs., Inc., v. Abbott Labs., 12-0312 (S.D. Ohio)

Apr. 10, 2012

Hon. Michael H. Watson

Norvir® (ritonavir tablets)

7,148,359

7,364,752

Purdue Pharma L.P. v. Varam, Inc., 12-2814 (S.D.N.Y.)

Apr. 10, 2012

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended release tablets)

5,508,042

7,674,799

7,674,800

7,683,072

AstraZeneca Pharma.

LP v. IntelliPharmaCeutics Corp., 12-2855 (S.D.N.Y.)

Apr. 11, 2012

Hon. Richard J. Sullivan

Seroquel XR® (quetiapine fumurate extended release tablets)

5,948,437

UCB, Inc. v. Mallinckrodt, Inc., 12-0463 (D. Del.)

Apr. 12, 2012

Hon. Leonard P. Stark

Metadate CD® (methylphenidate hydrochloride capsules)

6,344,215

Purdue Pharma L.P. v. Varam, Inc., 12-1898 (E.D. Pa.)

Apr. 12, 2012

Hon Petrese B. Tucker

OxyContin® (oxycodone hydrochloride extended release tablets)

5,508,042

7,674,799

7,674,800

7,683,072

Osi Pharma., LLC v. Roxane Labs., Inc., 12-0465 (D. Del.)

Apr. 13, 2012

Hon. Sue L. Robinson

Tarceva® (erlotinib hydrochloride tablets)

RE41,065

6,900,221

7,087,613

Pfizer, Inc. v. Dr. Reddy’s Labs., Ltd., 12-0467 (D. Del.)

Apr. 13, 2012

Hon. Leonard P. Stark

Caduet® (amlodipine besylate and atorvastatin calcium tablets)

6,455,574

Allergan, Inc. v. Sandoz, Inc., 12-0207 (E.D. Tex.)

Apr. 13, 2012

Hon. Rodney Gilstrap

Combigan® (brimonidine tartrate/timolol maleate ophthalmic solution, 0.2%/0.5%)

8,133,890

Purdue Pharma L.P. v. Mylan Pharma.

Inc., 12-2959 (S.D.N.Y.)

Apr. 13, 2012

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended release tablets)

7,674,799

7,674,800

7,683,072

Eli Lilly & Co. v. Apotex, Inc. 12-0499 (S.D. Ind.)

Apr. 17, 2012

Hon. Jane

Magnus-Stinson

Alimta® (pemetrexed disodium

injection)

7,772,209

Depomed, Inc. v. Watson Labs., Inc. - Florida, 12-0492 (D. Del.)

Apr. 18, 2012

Hon. Sue L. Robinson

Glumetza® (metformin hydrochloride extended release tablets)

6,488,962

7,780,987

Genzyme Corp. v. InvaGen Pharma., Inc., 12-1931 (E.D.N.Y.)

Apr. 19, 2012

Hon. Margo K. Brodie

Renvela® (sevelamer carbonate tablets

)

5,667,775

Purdue Pharma L.P. v. Watson Labs., Inc. – Florida, 12-3111 (S.D.N.Y.)

Apr. 19, 2012

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended release tablets)

8,114,383

Apotex, Inc. v. Mylan Pharma., Inc., 12-60704 (S.D. Fla.)

Apr. 20, 2012

Hon. Kathleen M. Willia

ms

Quinapril (quinapr

il hydrochloride and hydrochlorothiazide)

6,531,486

Apotex, Inc. v. Mylan Pharma., Inc., 12-60704 (S.D. Fla.)

Apr. 20, 2012

Hon. Kathleen M. Williams

quinapril hydrochloride

quinipril hydrochloride and hydrochlorothiazide

6,531,486

Apotex, Inc. v. Pfizer, Inc., 12-60705 (S.D. Fla.)

Apr. 20, 2012

Hon. K. Michael Moore

Accupril® (quinapril)

Accuretic® (hydrochlorothiazide and quinapril)

6,531,486

Apotex, Inc. v. UCB, Inc., 12-60706 (S.D. Fla.)

Apr. 20, 2012

Hon. Kathleen M. Williams

Univasc® (moexipril)

Uniretic® (moexipril HCl and hydrochlorothiazide)

6,767,556

Apotex, Inc. v. Paddock Labs., Inc., 12-60707 (S.D. Fla.)

Apr. 20, 2012

Hon. K. Michael Moore

moexipril

moexipril HCl and hydrochlrorthiazide

6,767,556

Apotex, Inc. v. Lupin Pharma., Inc., 12-60708 (S.D. Fla.)

Apr. 20, 2012

Hon. Donald M. Middlebrooks

quinapril hydrochloride

6,531,486

Genzyme Corp. v. Cobrek Pharma., Inc., 12-2937 (N.D. Ill.)

Apr. 20, 2012

Hon. Milton I. Shadur

Hectorol® (doxercalciferol injection)

5,602,116

Osi Pharma., LLC v. Roxane Labs., Inc., 12-2384 (D.N.J.)

Apr. 20, 2012

Hon. Dennis M. Cavanaugh

Tarceva® (erlotinib hydrochloride tablets)

RE41,065

6,900,221

7,087,613

Bayer Pharma AG v. Watson Pharma., Inc., 12-0517 (D. Del.)

Apr. 25, 2012

Hon. Gregory M. Sleet

Staxyn® (vardenafil HCl orally disintegrating tablets)

6,362,178

7,696,206

Abbott Labs. V. Agila Specialties Private Ltd., 12-0520 (D. Del.)

Apr. 25, 2012

Hon. Gregory M. Sleet

Zemplar® (paricalcitol injection)

6,136,799

6,361,758

5,597,815

Orion Corp. v. Mylan Pharma., Inc., 12-0523 (D. Del.)

Apr. 26, 2012

Hon. Gregory M. Sleet

Stalevo® (carbidopa, levodopa, and entacapone tablets)

5446194

6500867

6797732

Warner Chilcott Co., LLC v. Ranbaxy, Inc., 12-2474 (D.N.J.)

Apr. 26, 2012

Hon. Faith S. Hochberg

Atelvia® (risedronate sodium delayed release tablets)

7,645,459

7,645,460

Otsuka Pharma. Co., Ltd. v. Amneal Pharma., LLC, 12-2487 (D.N.J.)

Apr. 26, 2012

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

6,977,257

Teva Neuroscience, Inc. v. Sandoz Inc., 12-2494 (D.N.J.)

Apr. 26, 2012

Hon. Claire C. Cecchi

Azilect® (rasagiline mesylate tablets)

5,453,446

Valeant International (Barbados) SRL v. Sandoz, Inc., 12-0536 (D. Del.)

Apr. 30, 2012

Hon. Sherry R. Fallon

Aplenzin® (bupropion hydrobromide extended release tablets)

7,241,805

7,569,610

7,572,935

7,585,897

7,645,802

7,649,019

7,662,407

7,671,094

7,553,992

Shire Development LLC v. Watson Pharma., Inc., 12-60862 (S.D. Fla.)

May 8, 2012

Hon. Donald M. Middlebrooks

Lialda® (mesalamine delayed release tablets)

6,773,720

Depomed, Inc. v. Zydus Pharma.

(USA), Inc., 12-2813 (D.N.J.)

May 9, 2012

Hon. Joel A. Pisano

Gralise® (gabapentin tablets)

6,340,475

6,488,962

6,635,280

6,723,340

7,438,927

7,731,989

Janssen Products, L.P. v. Lupin Ltd., 12-2840 (D.N.J.)

May 10, 2012

Hon. William H. Walls

Prezista® (darunavir tablets)

RE42,889

Helsinn Healthcare S.A. v. Dr. Reddy’s Labs., Ltd., 12-2867 (D.N.J.)

May 11, 2012

Hon. Mary L. Cooper

Aloxi® (palonosetron hydrochloride intravenous solutions)

7,947,724

Novartis Pharma. Corp. v. Lupin Ltd., 12-0595 (D. Del.)

May 14, 2012

Hon. Sue L. Robinson

Exforge HCT® (amlodipine besylate, valsartan, and hydrochlorothiazide tablets)

6,294,197

8,101,599

Novartis Pharma. Corp. v. Torrent Pharma. Ltd., 12-0596 (D. Del.)

May 14, 2012

Hon. Sue L. Robinson

Exforge HCT® (amlodipine besylate, valsartan, and hydrochlorothiazide tablets)

6,294,197

8,101,599

Warner Chilcott Co., LLC v. Watson Labs., Inc., 12-2928 (D.N.J.)

May 16, 2012

Hon. Joel A. Pisano

Lo Loestrin® Fe (norethindrone acetate and ethinyl estradiol tablets)

5,552,394

7,704,984

Allergan, Inc. v. Hi-Tech Pharmacal Co., Inc., 12-0492 (M.D.N.C.)

May 16, 2012

Hon. Catherine C. Eagles

Latisse® (bimatoprost topical solution, 0.03%)

8,101,161

Cumberland Pharma.

Inc. v. Innopharma, Inc., 12-0618 (D. Del.)

May 17, 2012

Hon. Leonard P. Stark

Acetadote® (acetylcysteine for injection)

8,148,356

Cumberland Pharma. Inc. v. Paddock Labs., LLC, 12-0619 (D. Del.)

May 17, 2012

Hon. Leonard P. Stark

Acetadote® (acetylcysteine for injection)

8,148,356

Cumberland Pharma.

Inc. v. Mylan Institutional LLC, 12-3846 (N.D. Ill.)

May 17, 2012

Hon. Rebecca R. Pallmeyer

Acetadote® (acetylcysteine for injection)

8,148,356

Janssen Pharma., Inc. v. Haupt Pharma., Inc., 12-3034 (D.N.J.)

May 22, 2012

Hon. Stanley R. Chessler

Ortho Tri-Cyclen® LO (norgestimate and ethinyl estradiol)

6,214,815

Astellas US LLC v. Hospira, Inc., 12-0652 (D. Del.)

May 23, 2012

Hon. Sue L. Robinson

Adenoscan® (adenosine for injection)

5,731,296

Auxilium Pharma., Inc. v. Watson Labs., Inc.

(NV), 12-3084 (D.N.J.)

May 23, 2012

Hon. Jose L. Linares

Testim® (testosterone gel)

7,320,968

7,608,605

7,608,606

7,608,607

7,608,608

7,608,609

7,608,610

7,935,690

8,063,029

8,178,518

Pfizer Inc. v. Sandoz Inc., 12-0654 (D. Del.)

May 24, 2012

Hon. Gregory M. Sleet

Torisel® (temsirolimus for injection)

8,026,276

Shire Development, LLC v. Mylan Pharma., Inc., 12-1190 (M.D. Fla.)

May 25, 2012

Hon. James S. Moody, Jr.

Lialda® (mesalamine delayed release tablets)

6,773,720

Merck Sharp & Dohme Corp. v. Sandoz Inc., 12-3289 (D.N.J.)

May 31, 2012

Hon. Peter G. Sheridan

Emend® (fosaprepitant dimeglumine for injection)

5,691,336

5,716,942

Merck Sharp & Dohme Corp. v. Accord Healthcare, Inc. USA, 12-3324 (D.N.J.)

June 1, 2012

Hon. Peter G. Sheridan

Emend® (fosaprepitant dimeglumine for injection)

5,691,336

5,716,942

Abbott Labs. v. Kremers Urban Pharma., Inc., 12-0703 (D. Del.)

June 1, 2012

Hon. Sue L. Robinson

Niaspan® (niacin extended release tablets)

6,080,428

6,469,035

Medicis Pharma. Corp. v. Zydus Pharma. USA Inc., 12-0707 (D. Del.)

June 4, 2012

Hon. Leonard P. Stark

Solodyn® (minocycline HCl extended release tablets)

5,908,838

7,790,705

7,919,483

Medicis Pharma. Corp. v. Zydus Pharma. USA Inc., 12-3368 (D. Del.)

June 5, 2012

Hon. Freda L. Wolfson

Solodyn® (minocycline HCl extended release tablets)

5,908,838

7,790,705

7,919,483

Janssen Products, L.P. v. Teva Pharma. USA, Inc., 12-3569 (D.N.J.)

June 13, 2012

Hon. William H. Walls

Prezista® (darunavir)

RE42,889

Janssen Products, L.P. v. Hetero Drugs, Ltd., 12-3570 (D.N.J.)

June 13, 2012

Hon. William H. Walls

Prezista® (darunavir)

RE42,889

Bristol-Myers Squibb Co. v. Sandoz Inc., 12-0787 (D. Del.)

June 21, 2012

Hon. Richard G. Andrews

Baraclude® (entecavir tablets)

5,206,244

Pfizer Inc. v. Anchen Pharma., Inc., 12-0808 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Apotex, Inc., 12-0809 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Breckenridge Pharmaceitucal, Inc., 12-0810 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Lupin Ltd., 12-0811 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Mylan Pharma. Inc., 12-0812 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Roxane Labs. Inc., 12-0813 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Sandoz Inc., 12-0814 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Teva Pharma. USA Inc., 12-0815 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Watson Labs. Inc.—Florida, 12-0816 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Wockhardt Ltd., 12-0817 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Zydus Pharma. USA Inc., 12-0818 (D. Del.)

June 22, 2012

Unassigned

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Sandoz Inc., 12-3880 (D.N.J.)

June 25, 2012

Hon. Peter G. Sheridan

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Zydus Pharma. USA Inc., 12-3893 (D.N.J.)

June 25, 2012

Hon. Peter G. Sheridan

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Watson Labs. Inc.—Florida, 12-61268 (S.D. Fla.)

June 25, 2012

Hon. Robin S. Rosenbaum

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Pfizer Inc. v. Anchen Pharma., Inc., 12-5535 (C.D. Cal.)

June 25, 2012

Hon. George H. King

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Galderma Labs. L.P. v. Actavis Mid Atlantic LLC, 12-2038 (N.D. Tex.)

June 26, 2012

Hon. A. Joe Fish

Epiduo® (adapalene and benzoyl peroxide gel)

7,820,186

7,964,202

8,071,644

8,080,537

8,105,618

8,129,362

Pfizer Inc. v. Mylan Pharma. Inc., 12-0106 (N.D.W.V.)

June 26, 2012

Hon. Irene M. Keeley

Pristiq® (O-desmethylvenlafaxine succinate extended release tablets)

6,673,838

Cumberland Pharma. Inc. v. Sagent Agila LLC, 12-0825 (D. Del.)

June 26, 2012

Unassigned

Acetadote® (acetylcysteine for injection)

8,148,356

Novartis Pharma. Corp. v. Wockhardt USA LLC, 12-3967 (D.N.J.)

June 27, 2012

Hon. Susan D. Wigenton

Reclast® (zoledronic acid for injection)

Zometa® (zoledronic acid for injection)

7,932,241

8,052,987

Purdue Pharma L.P. v. Sandoz, Inc., 12-5082 (S.D.N.Y.)

June 28, 2012

Unassigned

OxyContin® (oxycodone hydrochloride extended release tablets)

8,114,383

Purdue Pharma L.P. v. Teva Pharma. USA, Inc., 12-5083 (S.D.N.Y.)

June 28, 2012

Unassigned

OxyContin® (oxycodone hydrochloride extended release tablets)

8,114,383

Endo Pharma. Inc. v. Noven Pharma., Inc., 12-0831 (D. Del.)

June 29, 2012

Unassigned

Lidoderm® (lidocaine transdermal)

5,827,529

Alkermes Pharma Ireland Ltd. v. Intellipharmaceutics Corp., 12-0834 (D. Del.)

June 29, 2012

Unassigned

Focalin® XR (dexmethylphenidate hydrochloride capsules)

6,228,398

6,730,325

Abbott Labs. v. Sandoz, Inc., 12-0836 (D. Del.)

June 29, 2012

Unassigned

Zemplar® (paricalcitol capsules)

5,587,497

5,597,815

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.